Autologous Protein Injection (API) 
nSTRIDE® Treatment

Intra-Articular Injection for the Treatment of Knee Osteoarthritis (OA)

 

Once the pain of osteoarthritis starts it is hard to stop. The n-STRIDE APS technology is designed to produce a ground-breaking autologous therapy to treat pain and slow the progression of cartilage degradation and destruction. The n-STRIDE APS technology is a cell-concentration system which concentrates anti-inflammatory cytokines and anabolic growth factors to significantly decrease pain and promote cartilage health. 

 

 

Pre-Clinical & Clinical

 

• Significantly reduces pain associated with knee OA

• Significantly improves function in the knee joint associated with OA

• Stimulates cartilage cell proliferation

• Blocks cartilage destruction

• Slows cartilage degradation

• Point of care

• Single-injection treatment

 

​